Blood biomarkers predicting adverse clinical outcomes in congenital heart disease patients, with consideration for pulmonary valve replacement

Pubblicato online: 29 mar 2023

Pagine: 11 - 16

Ricevuto: 20 ott 2022

Accettato: 14 feb 2023

DOI: https://doi.org/10.2478/amma-2023-0009

Parole chiave

congenital heart disease, tetralogy of Fallot, pentalogy of Fallot, blood biomarkers, pulmonary valve replacement

© 2023 Milla Marika Kainlauri et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.